期刊文献+

髓系/自然杀伤细胞前体细胞急性白血病一例并文献复习

原文传递
导出
摘要 目的提高对髓系/自然杀伤细胞前体细胞急性白血病的认识。方法报道一例髓系/自然杀伤细胞前体细胞急性白血病的临床特点、诊断和治疗经过,并进行文献复习。结果以DA方案治疗2个疗程后达完全缓解,此后以大剂量阿糖胞苷巩固化疗,目前患者处于持续完全缓解状态。结论髓系/自然杀伤细胞前体细胞急性白血病对急性髓系白血病化疔方案的反应优于对急性淋巴细胞白血病化疗方案的反应,参照急性髓系白血病的化疗方案大部分可以达到完全缓解,但总体来说缓解期短,缓解后易复发,患者的中位生存期仅为19个月。
出处 《白血病.淋巴瘤》 CAS 2009年第12期756-757,共2页 Journal of Leukemia & Lymphoma
关键词 白血病
  • 相关文献

参考文献4

  • 1Oshimi K. Progress in understanding and managing natural killer-cell malignancies. Br J Haematol, 2007, 139:532-544.
  • 2Suzuki R, Yamamoto K, Seto M, et al. CD7^+ and CD56^+myeloid / natural killer cell precursor acute leukemia:a distinct hematolymphoid disease entity. Blood, 1997, 90: 2417-2428.
  • 3张莉,王世宏,李睿,宫本法,王慧君,郝玉书,肖志坚.髓系/自然杀伤细胞祖细胞急性白血病(附1例报道并文献复习)[J].白血病.淋巴瘤,2004,13(6):326-329. 被引量:6
  • 4Scott AA, Head DR, Kopecky KJ, et al. HLA-DR ,CD33^+, CD56^+,CD16^- myeloid / natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood, 1994, 84: 244-255.

二级参考文献13

  • 1Tezuka K, Nakayama H, Honda K, et al. Treatment of a child with myeloid/N K cell precursor acute leukemia with L-asparaginase and unrelated cord blood transplantation[J]. Int J Hematol, 2002, 75:201-206.
  • 2Scott A A, Head D R, Kopecky K J, et al. HLA-DR-, CD33+, CD56+,CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as FrenchAmerican-British acute myeloid leukemia-M3[J]. Blood, 1994,
  • 3Shimamoto T, Nakajima A, Katagiri T, et al. Myeloid/natural killer cell precursor acute leukemia accompanied by homozygous protein C deficiency[J]. Int J Hematol, 2003, 78:149-153.
  • 4Handa H, Motohashi S, Isozumi K, et al. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia treated with idarubicin and cytosine arabinoside[J]. Acta Haematol, 2002, 108:47-52.
  • 5Suzuki R, Yamamoto K, Seto M, et al. CD7+ and CD+56 myeloid/natural killer cell precursoracute leukemia: a distinct hematolymphoid disease entity[J]. Blood, 1997,90: 2417-2428.
  • 6Dubois S, Etzell J E, Matthay K K, et al. Pediatric acute blastic natural killer cell leukaemia[J]. Leuk Lymphoma, 2002,43:901-906.
  • 7Suzuki R, Suzumiya J, Nakamura S, et al. Aggressive natural killer-cell leukemia revisited: large granular lymphocyte leukemia of cytotoxic NK cells[J]. Leukemia, 2004, 18:763-770.
  • 8Suzuki R, Murata M, Kami M,et al. Prognostic significance of CD7+CD56+ phenotype and chromosome 5 abnormalities for acute myeloid leukemia M0[J]. Int J Hematol, 2003, 77:482-489.
  • 9Suzuki R, Nakamura S. Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia[J]. Leuk Res, 1999,23:615-624.
  • 10Inaba T, Shimazaki C, Sumikuma T, et al. Clinicopathological features of myeloid/natural killer (NK) cell precursor acute leukemia[J]. Leuk Res,2001,25:109-113.

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部